Racial differences in the cost of treating men with early-stage prostate cancer

Abstract

Objective: To compare the cost and resource utilization in the evaluation, treatment, and 6-month follow-up of African-American and White men undergoing either external beam radiation therapy (XRT) or radical prostatectomy (RP) for early-stage prostate cancer.

Design: Retrospective analysis of cost and resource utilization data from encrypted patient-specific hospital inpatient, hospital outpatient, and physician/supplier data files.

Setting: National Medicare claims data from 1993 through 1996.

Participants: A random 5% national sample of Medicare beneficiaries from the Health Care Financing Administration Public Use Files for 1993 through 1996.

Measurements: Inpatient, outpatient, and physician/supplier Medicare costs.

Results: African-American men undergoing RP for early-stage prostate cancer had significantly higher costs ($21,878 vs $18,786, P < .0001) than did White men. Most of the difference occurred in the inpatient setting. African-American men undergoing XRT had significantly greater costs ($18,131 vs $15,734, P < .0001) than did White men. Most of this difference was generated by longer duration of XRT treatments.

Conclusions: In early-stage prostate cancer, charges for RP and XRT in African-American men are higher when compared with those for White men.